BioPharma Credit PLC (MUN:B3P)
Germany · Delayed Price · Currency is EUR 0.7950
0.00 (0.00%)
At close: Dec 1, 2025
BioPharma Credit Market Cap
BioPharma Credit has a market cap or net worth of €864.16 million as of December 15, 2025. Its market cap has decreased by -13.06% in one year.
Market Cap
864.16M
Enterprise Value
860.50M
Revenue
131.70M
Ranking
n/a
PE Ratio
8.24
Stock Price
€0.80
Market Cap Chart
Since March 27, 2017, BioPharma Credit's market cap has increased from 499.76M to 864.16M, an increase of 72.92%. That is a compound annual growth rate of 6.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 864.16M | -14.75% |
| Dec 31, 2024 | 1.01B | 2.39% |
| Dec 29, 2023 | 989.97M | -15.58% |
| Dec 30, 2022 | 1.17B | 0.28% |
| Dec 31, 2021 | 1.17B | 4.54% |
| Dec 31, 2020 | 1.12B | -10.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 244.16B |
| Siemens Aktiengesellschaft | 186.18B |
| Allianz SE | 145.75B |
| Deutsche Telekom AG | 126.33B |
| Siemens Energy AG | 101.53B |
| Rheinmetall AG | 72.19B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 61.07B |